Get the Stockscreener App
3.13
4.57%
-0.15
After Hours:
3.21
0.08
+2.56%
Rezolute Inc stock is traded at $3.13, with a volume of 1.34M.
It is down -4.57% in the last 24 hours and up +7.19% over the past month.
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
See More
Previous Close:
$3.28
Open:
$3.26
24h Volume:
1.34M
Relative Volume:
0.20
Market Cap:
$299.53M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-2.4646
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
-4.86%
1M Performance:
+7.19%
6M Performance:
-60.88%
1Y Performance:
-21.36%
1-Day Range:
$3.06
$3.30
1-Week Range:
$2.93
$3.42
52-Week Range:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
3.13 | 313.89M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-11-25 | Downgrade | Craig Hallum | Buy → Hold |
| Dec-11-25 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-05-24 | Initiated | Wedbush | Outperform |
| Aug-27-24 | Initiated | Guggenheim | Buy |
| Jul-17-24 | Initiated | BTIG Research | Buy |
| Jun-04-24 | Initiated | Craig Hallum | Buy |
| Apr-09-24 | Initiated | Maxim Group | Buy |
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
View All
Rezolute Inc Stock (RZLT) Latest News
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT) - marketscreener.com
Rezolute to Participate in the Citizens Life Sciences Conference - The Manila Times
Biotech Rezolute plans investor meetings at Miami life sciences event - Stock Titan
RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Nasdaq
RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PR Newswire
Legal Scrutiny Follows Rezolute's Clinical Trial Setback - AD HOC NEWS
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Bluefield Daily Telegraph
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
RZLT.O Should I Buy - Intellectia AI
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Craig-Hallum Remains a Hold on Rezolute (RZLT) - The Globe and Mail
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN
Q1 Earnings Estimate for Rezolute Issued By HC Wainwright - MarketBeat
Will Rezolute Inc. benefit from rate cutsEarnings Summary Report & Consistent Profit Focused Trading Strategies - mfd.ru
RZLT SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com
How Rezolute Inc. stock reacts to global recession fearsJuly 2025 Price Swings & Stepwise Swing Trade Plans - mfd.ru
Oculis and Rezolute Contrast Financial Strength - National Today
Biotech Company Advances Breakthrough Hyperinsulinism Treatment - streetwisereports.com
Rezolute Reports Q2 Loss, Downgrades Ahead - Intellectia AI
MSN Money - MSN
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Beh - GuruFocus
Is Rezolute Inc. a top pick in the sectorWeekly Investment Recap & High Return Stock Watch Alerts - mfd.ru
Is Rezolute Inc. benefiting from interest rate changesWeekly Trade Summary & Long-Term Safe Investment Ideas - mfd.ru
Rezolute (NASDAQ:RZLT) Announces Quarterly Earnings Results - MarketBeat
Rezolute (RZLT) Reports Decline in Cash Reserves by Year-End - GuruFocus
Phase 3 miss hits Rezolute (NASDAQ: RZLT) as losses widen and cash burn rises - Stock Titan
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - The Manila Times
Press Release: Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - 富途牛牛
Rare hypoglycemia drug misses trial goals, yet patients stay on it - Stock Titan
Is Rezolute Inc. backed by strong institutional buyingTrade Exit Report & Short-Term Swing Trade Alerts - mfd.ru
Can Rezolute Inc. navigate macro headwindsInflation Watch & Proven Capital Preservation Tips - mfd.ru
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire Inc.
Can Rezolute Inc. stock hit record highs againWeekly Trend Recap & Weekly High Potential Stock Alerts - mfd.ru
Faruqi & Faruqi Investigates Losses in Rezolute Stock - Intellectia AI
Surprises Report: Is Rezolute Inc stock trending bullishJuly 2025 Recap & Community Verified Swing Trade Signals - baoquankhu1.vn
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com
Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Rezolute, Inc. to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative
Rezolute (RZLT) Projected to Post Earnings on Wednesday - MarketBeat
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investig - The National Law Review
Profit Recap: Should I hold or sell Lumen Technologies Inc nowForecast Cut & Proven Capital Preservation Methods - baoquankhu1.vn
Rezolute’s Phase 3 SunRIZE study for Ersodetug fails to meet primary and secondary endpoints despite analyst backing - MSN
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP - GlobeNewswire
Rezolute, Inc. (NASDAQ:RZLT) Sees Significant Increase in Short Interest - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Rezolute (NASDAQ:RZLT) Shares Down 3.8%What's Next? - MarketBeat
Faruqi & Faruqi Encourages Rezolute Investors to Discuss Legal Options - intellectia.ai
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):